ASH 2024: Lu Daopei Team Showcases 13 Research Achievements in Hematology

The 66th Annual Meeting of the American Society of Hematology (ASH) is set to take place from December 7 to 10, 2024, in San Diego, California. As the largest and most comprehensive event in the field of hematology, this year’s conference will feature hundreds of discussions on cutting-edge advancements, attracting over 27,000 hematologists and healthcare professionals from more than 100 countries.

This year, ASH received over 7,000 abstract submissions, with a rigorous selection process resulting in those representing significant innovations in hematology. A prominent voice for Chinese hematology, the Lu Daopei Hospital medical team is proud to present 13 research achievements at this year’s conference, showcasing their growing excellence in scientific research.

Among the notable abstracts is a study on the "Comprehensive Fusion Gene Landscape in B-cell Lymphoblastic Leukemia," presented by Dr. Xue Chen, and another exploring "CD7-Targeted CAR-T Cell Therapy," demonstrating promising efficacy and safety in treating refractory peripheral T-Cell Lymphoma.

The research encompasses a wide range of topics, from hematopoietic stem cell transplantation to laboratory diagnostics, reflecting the comprehensive technical expertise and innovative research capabilities of the Lu Daopei Hospital team. Their contributions not only highlight the dual strength of scientific innovation and clinical practice but also reinforce their commitment to advancing treatments for hematological disorders.

As the conference approaches, the Lu Daopei Hospital team looks forward to sharing these research findings with the global hematology community and will provide detailed reports following the event. Stay tuned for more updates!